Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic equivalence of Fluticasone MDI formulations in adult bronchial asthma
jRCT2080220646Phase 2
- Sponsor
- Kyorin Pharmaceutical
- Start
- Dec 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of fluticasone in asthma (2 arms), sponsored by Kyorin Pharmaceutical.
02
Drugs
fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on jRCT2080220646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220646.